Innovex International
INVX NYSE Oil & Gas Equipment & Services Financials FY2016βFY2025
Innovex International's revenue rose 48.0% to $978 million in fiscal 2025. Its operating margin was 13.6%, up from 7.4% a year earlier. It paid out $9 million in dividends and buybacks. The diluted share count rose 37.0%.
What Innovex International does
No business description yet.
- Legal name
- INNOVEX INTERNATIONAL, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-067228
0001042893
Revenue and margins
Innovex International had $978M of revenue in fiscal 2025, up 48.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β7.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Innovex International returned $9.3M to shareholders in fiscal 2025. The diluted share count rose 37.0%.
Value Innovex International yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $178M and divides by 69.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 33.6x Β· peers 35.2x Β· sector 16.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Innovex International can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $356M | $292M | $213M | β | $203M |
| Debt incl. finance leases | β | β | $50.4M | $35.8M | $25.6M |
| Net debt / EBITDA | β | β | β1.4x | β | β0.9x |
| Debt / equity | β | β | 0.2x | 0.0x | 0.0x |
| Interest coverage | β159.3x | 18.8x | 17.7x | 20.2x | 51.4x |
| Current ratio | 8.0x | 8.6x | 3.7x | 3.9x | 4.9x |
| Quick ratio | 6.4x | 6.9x | 1.9x | 2.3x | 3.2x |
| Total assets | $1.0B | $970M | $475M | $1.2B | $1.3B |
| Total liabilities | $113M | $97.6M | $146M | $239M | $211M |
| Shareholders' equity | $181M | $251M | $329M | $958M | $1.1B |
| Net debt (β = net cash) | β | β | β$163M | β | β$178M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$308M
4 insiders
Of sales under plans
100%
$308M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Jason TurowskyDirector, 10% owner | Sold plan | 5,000,000 | $28.71 | $144M | Form 4 |
| Aug 4, 2026 | Mark ReddoutPresident of North America | Sold plan | 10,000 | $30.00 | $0.3M | Form 4 |
| Jun 2, 2026 | Mark ReddoutPresident of North America | Sold plan | 10,750 | $28.00 | $0.3M | Form 4 |
| Feb 27, 2026 | Interval Capital Associates II LLCDirector, 10% owner | Sold plan | 6,612,500 | $24.59 | $163M | Form 4 |
| Feb 24, 2026 | Adam AndersonChief Executive Officer, Director | Sold plan | 18,837 | $28.50 | $0.5M | Form 4 |
| Feb 23, 2026 | Adam AndersonChief Executive Officer, Director | Sold plan | 13,241 | $27.00 | $0.4M | Form 4 |
| Jan 14, 2026 | Adam AndersonChief Executive Officer, Director | Sold plan | 13,241 | $25.00 | $0.3M | Form 4 |
| Jan 14, 2026 | Mark ReddoutPresident of North America | Sold plan | 20,000 | $25.00 | $0.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β0.3% | 5.6% | β8.7% |
| Altman Z'' | 7.63 | 7.68 | 9.71 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Innovex International INVX | $2.1B | 48.0% | 13.6% | β | β | 33.6x | 5 | |
| Cactus WHD | β | β4.5% | 23.2% | β | 17.1% | β | β | Compare β |
| Atlas Energy Solutions AESI | $1.1B | 3.7% | β1.0% | β2.8% | β | β | 4 | Compare β |
| Kodiak Gas Services KGS | $4.3B | 12.8% | 26.0% | 21.7% | 6.3% | 52.8x | 5 | Compare β |
| Tidewater TDW | $4.3B | 0.5% | 20.9% | 26.1% | 19.4% | 17.6x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $539M | $456M | $385M | $415M | $365M | $322M | $362M | $424M | $661M | $978M |
| Gross profit | $210M | $125M | $91.1M | $120M | $95.3M | $13.2M | $52.9M | $64.0M | $233M | $303M |
| Research and development | β | β | β | β | β | β | $2.5M | $3.0M | $3.7M | $6.7M |
| Operating income | $113M | β$69.1M | β$123M | $2.8M | β$63.6M | β$125M | $75.8M | $97.3M | $49.1M | $133M |
| Interest expense | $0.0M | $0.1M | $0.3M | $0.3M | $0.6M | $0.8M | $4.0M | $5.5M | $2.4M | $2.6M |
| Pretax income | $116M | β$65.6M | β$115M | $10.4M | β$62.0M | β$126M | $72.9M | $94.4M | $143M | $129M |
| Income tax | $22.6M | $35.0M | β$19.3M | $8.7M | β$31.3M | $2.9M | $9.7M | $20.4M | $2.5M | $45.2M |
| Net income | $93.2M | β$101M | β$95.7M | $1.7M | β$30.8M | β$129M | $63.3M | $73.9M | $140M | $83.3M |
| Diluted EPS | $2.47 | β$2.69 | β$2.58 | $0.05 | β$0.87 | β$3.63 | $2.01 | $2.29 | $2.77 | $1.20 |
| Diluted shares | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.03B | 0.03B | 0.05B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $247M | $108M | $45.5M | $14.7M | β$21.1M | $38.4M | β$5.8M | $75.9M | $93.4M | $191M |
| Capital expenditure | $25.8M | $27.6M | $32.1M | $11.5M | $11.9M | $10.0M | $18.9M | $32.6M | β | β |
| Free cash flow | $221M | $80.4M | $13.4M | $3.2M | β$33.0M | $28.4M | β$24.7M | $43.2M | β | β |
| Depreciation and amortization | $31.9M | $41.0M | $35.3M | $34.0M | $32.4M | $30.4M | $18.5M | $22.7M | $31.2M | $60.7M |
| Stock-based compensation | $12.2M | $14.3M | $13.5M | $15.7M | $12.9M | $14.9M | $0.9M | $2.0M | $13.2M | $13.8M |
| Acquisitions | $132M | $20.4M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $82.3M | $65.5M | $83.7M |
| Share buybacks | $24.2M | $0.0M | $100M | $26.6M | $25.0M | $24.2M | $20.8M | $0.0M | $0.0M | $9.3M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $75.0M | $0.0M |
| Dividends and buybacks | $24.2M | $0.0M | $100M | $26.6M | $25.0M | $24.2M | $20.8M | $0.0M | $75.0M | $9.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $424M | $493M | $418M | $399M | $346M | $356M | $292M | $213M | β | $203M |
| Total debt | β | β | β | β | β | β | β | $50.4M | $25.4M | $25.6M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.5M | $0.2M | $0.1M | $0.1M | $1.1M | $10.3M | $25.6M |
| Current assets | $1.1B | $1.0B | $853M | $881M | $863M | $745M | $750M | $288M | $641M | $728M |
| Current liabilities | $102M | $99.9M | $81.5M | $96.9M | $85.5M | $93.7M | $87.6M | $78.6M | $163M | $148M |
| Inventory | $355M | $291M | $191M | $205M | $213M | $146M | $146M | $141M | $271M | $248M |
| Property and equipment, net | $323M | $284M | $274M | $259M | $235M | $216M | $181M | $52.4M | $191M | $159M |
| Total assets | $1.5B | $1.4B | $1.2B | $1.2B | $1.2B | $1.0B | $970M | $475M | $1.2B | $1.3B |
| Total liabilities | $105M | $105M | $96.3M | $116M | $110M | $113M | $97.6M | $146M | $239M | $211M |
| Shareholders' equity | $1.4B | $1.3B | $1.1B | $1.1B | $1.0B | $181M | $251M | $329M | $958M | $1.1B |
| Margins | ||||||||||
| Gross margin | 39.0% | 27.5% | 23.7% | 28.9% | 26.1% | 4.1% | 14.6% | 15.1% | 35.2% | 31.0% |
| Operating margin | 21.0% | β15.2% | β31.9% | 0.7% | β17.4% | β38.9% | 21.0% | 22.9% | 7.4% | 13.6% |
| EBITDA margin | 26.9% | β6.2% | β22.7% | 8.9% | β8.5% | β29.5% | 26.1% | 28.3% | 12.2% | 19.8% |
| Net margin | 17.3% | β22.1% | β24.9% | 0.4% | β8.4% | β39.9% | 17.5% | 17.4% | 21.2% | 8.5% |
| FCF margin | 41.0% | 17.7% | 3.5% | 0.8% | β9.1% | 8.8% | β6.8% | 10.2% | β | β |
| Returns | ||||||||||
| Return on capital employed | 8.4% | β5.2% | β10.2% | 0.3% | β5.8% | β12.7% | 8.4% | 15.2% | 6.9% | 12.3% |
| Return on equity | 7.0% | β7.6% | β8.0% | 0.2% | β2.9% | β21.0% | 29.3% | 25.5% | 21.8% | 8.3% |
| Return on assets | 6.5% | β7.0% | β7.4% | 0.1% | β2.6% | β11.9% | 6.4% | 10.2% | 16.8% | 6.8% |
| Growth | ||||||||||
| Revenue growth | β36.2% | β15.5% | β15.6% | 7.9% | β12.0% | β11.7% | 12.2% | 17.2% | 55.8% | 48.0% |
| Net income growth | β51.5% | β208.0% | β | β | β1,888.8% | β | β | 16.8% | 89.8% | β40.6% |
| EPS growth | β50.4% | β208.9% | β | β | β1,840.0% | β | β | 13.9% | 21.0% | β56.7% |
| FCF growth | 35.4% | β63.6% | β83.3% | β76.4% | β1,139.7% | β | β186.8% | β | β | β |
| Share count change | β2.2% | β0.6% | β1.0% | β2.5% | β2.5% | 0.2% | β11.0% | 2.9% | 56.6% | 37.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | β1.4x | β | β0.9x |
| Debt / equity | β | β | β | β | β | β | β | 0.2x | 0.0x | 0.0x |
| Interest coverage | 4,030.7x | β960.2x | β421.8x | 8.9x | β102.4x | β159.3x | 18.8x | 17.7x | 20.2x | 51.4x |
| Current ratio | 10.4x | 10.1x | 10.5x | 9.1x | 10.1x | 8.0x | 8.6x | 3.7x | 3.9x | 4.9x |
| Quick ratio | 6.9x | 7.2x | 8.1x | 7.0x | 7.6x | 6.4x | 6.9x | 1.9x | 2.3x | 3.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.8% | 6.1% | 8.3% | 2.8% | 3.3% | 3.1% | 5.2% | 7.7% | β | β |
| Stock comp / revenue | 2.3% | 3.1% | 3.5% | 3.8% | 3.5% | 4.6% | 0.3% | 0.5% | 2.0% | 1.4% |
| Payouts / FCF | 11.0% | 0.0% | 743.9% | 836.3% | β | 85.1% | β | 0.0% | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | β | β | β | 7.0 | 5.0 |
| Altman Z'' | 21.7 | 20.1 | 18.8 | 17.4 | 17.2 | 8.2 | 10.9 | 7.6 | 7.7 | 9.7 |
| Accruals ratio | β10.6% | β14.6% | β10.9% | β1.1% | β0.8% | β15.5% | 7.0% | β0.3% | 5.6% | β8.7% |
Source: SEC EDGAR XBRL filings (CIK 0001042893). Data updated October 21, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.